Biotech Values

[DewDiligence]

ICGN shareholders tendered enough shares to PFE to give PFE a majority of the shares outstanding on a fully-diluted basis, which makes the merger a fait accompli:

http://finance.yahoo.com/news/Pfizer-Announces-Successful-bw-3152173878.html?x=0&.v=1

The only question is whether PFE will have to conduct a (dummy) vote of ICGN shareholders or whether PFE will be able to close the deal via a short-form merger, which does not require a vote.